Literature DB >> 30932199

Autophagy in pulmonary hypertension: Emerging roles and therapeutic implications.

Chun-Fang Zhang1, Fang-Yun Zhao2, Shuang-Lan Xu1, Jie Liu1, Xi-Qian Xing1, Jiao Yang3.   

Abstract

Autophagy is an important mechanism for cellular self-digestion and basal homeostasis. This gene- and modulator-regulated pathway is conserved in cells. Recently, several studies have shown that autophagic dysfunction is associated with pulmonary hypertension (PH). However, the relationship between autophagy and PH remains controversial. In this review, we mainly introduce the effects of autophagy-related genes and some regulatory molecules on PH and the relationship between autophagy and PH under the conditions of hypoxia, monocrotaline injection, thromboembolic stress, oxidative stress, and other drugs and toxins. The effects of other autophagy-related drugs, such as chloroquine, 3-methyladenine, rapamycin, and other potential therapeutic drugs and targets, in PH are also described.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  autophagy; pulmonary artery endothelial cells; pulmonary artery smooth muscle cells; pulmonary hypertension

Mesh:

Year:  2019        PMID: 30932199     DOI: 10.1002/jcp.28531

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

Review 1.  Endosomes and Autophagy: Regulators of Pulmonary Endothelial Cell Homeostasis in Health and Disease.

Authors:  Havovi Chichger; Sharon Rounds; Elizabeth O Harrington
Journal:  Antioxid Redox Signal       Date:  2019-07-31       Impact factor: 8.401

Review 2.  Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension.

Authors:  Dan Xu; Ya-Hui Hu; Xue Gou; Feng-Yang Li; Xi-Yu-Chen Yang; Yun-Man Li; Feng Chen
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

3.  Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension.

Authors:  Ya-Ru Bao; Jing-Wei Chen; Yan Jiang; Lin-Hui Wang; Rong Xue; Jin-Xian Qian; Guo-Xing Zhang
Journal:  Front Pharmacol       Date:  2020-05-21       Impact factor: 5.810

4.  Protein expression profile changes of lung tissue in patients with pulmonary hypertension.

Authors:  Min Wu; Yijin Wu; Jinsong Huang; Yueheng Wu; Hongmei Wu; Benyuan Jiang; Jian Zhuang
Journal:  PeerJ       Date:  2020-01-31       Impact factor: 2.984

Review 5.  Reactive Oxygen Species and Oxidative Stress in Vascular-Related Diseases.

Authors:  Xin-Meng Cheng; Yu-Yuan Hu; Tao Yang; Nan Wu; Xue-Ning Wang
Journal:  Oxid Med Cell Longev       Date:  2022-04-04       Impact factor: 6.543

6.  Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway.

Authors:  Haitao Liu; Sha Zhang; Yi Liu; Jing Ma; Wei Chen; Tao Yin; Tongbin Li; Bin Liang; Ling Tao
Journal:  Respir Res       Date:  2022-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.